Everybody’s been denied some form of care,’ said one California mental health advocate. Now, lawmakers are advancing new ...

More older Americans are challenging their Medicare Advantage plan's denial of a service, and it's paying off.

Elizabeth Jones, MD, FAAD, highlights the persistent issue of insurance companies favoring expensive, newer medications over equally effective generics in dermatology, emphasizing the time-consuming ...

Q4 2024 Earnings Call Transcript March 20, 2025 ARS Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.52, ...